-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Cancer cachexia: an unmet need in cancer treatment
Ozkan Kanat, Bert H O ™Neil
Commentary: Clinical Investigation
-
Cancer cachexia: an unmet need in cancer treatment
Ozkan Kanat, Bert H O ™Neil
Commentary: Clinical Investigation
-
Cancer cachexia: an unmet need in cancer treatment
Ozkan Kanat, Bert H O ™Neil
Commentary: Clinical Investigation
-
Cancer cachexia: an unmet need in cancer treatment
Ozkan Kanat, Bert H O ™Neil
Commentary: Clinical Investigation
-
Cancer cachexia: an unmet need in cancer treatment
Ozkan Kanat, Bert H O ™Neil
Commentary: Clinical Investigation
-
Cancer cachexia: an unmet need in cancer treatment
Ozkan Kanat, Bert H O ™Neil
Commentary: Clinical Investigation
-
Cancer cachexia: an unmet need in cancer treatment
Ozkan Kanat, Bert H O ™Neil
Commentary: Clinical Investigation
-
Cancer cachexia: an unmet need in cancer treatment
Ozkan Kanat, Bert H O ™Neil
Commentary: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation